Palvella Therapeutics (PVLA) Capital Expenditures Growth (3y) (2017 - 2023)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 46.88% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 8.97% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 16.27% |
| 10 | Palvella Therapeutics | 1.47 Bn | 1.21 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -32.35% |
| Sep 30, 2023 | 28.68% |
| Jun 30, 2023 | -70.95% |
| Mar 31, 2023 | -70.80% |
| Dec 31, 2022 | -4.95% |
| Sep 30, 2022 | -58.99% |
| Jun 30, 2022 | -32.06% |
| Mar 31, 2022 | 35.04% |
| Dec 31, 2021 | 18.87% |
| Sep 30, 2021 | -40.79% |
| Jun 30, 2021 | -16.55% |
| Mar 31, 2021 | -59.26% |
| Dec 31, 2020 | -10.97% |
| Sep 30, 2020 | -69.93% |
| Jun 30, 2020 | 16.97% |
| Mar 31, 2020 | 120.81% |
| Dec 31, 2019 | 70.49% |
| Sep 30, 2019 | 5.41% |
| Jun 30, 2019 | 154.37% |
| Mar 31, 2019 | 21.23% |
| Dec 31, 2018 | 17.14% |
| Sep 30, 2018 | 18.57% |
| Jun 30, 2018 | 127.10% |
| Mar 31, 2018 | 116.76% |
| Jun 30, 2017 | 411.27% |
| Mar 31, 2017 | 366.08% |